ID PLD2_BOVIN Reviewed; 933 AA. AC Q0V8L6; Q08DV7; DT 17-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 05-SEP-2006, sequence version 1. DT 16-JUN-2009, entry version 25. DE RecName: Full=Phospholipase D2; DE Short=PLD 2; DE EC=3.1.4.4; DE AltName: Full=Choline phosphatase 2; DE AltName: Full=Phosphatidylcholine-hydrolyzing phospholipase D2; GN Name=PLD2; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; OC Pecora; Bovidae; Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=16305752; DOI=10.1186/1471-2164-6-166; RA Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L., RA Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.; RT "Characterization of 954 bovine full-CDS cDNA sequences."; RL BMC Genomics 6:166-166(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Fetal pons; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: May have a role in signal-induced cytoskeletal CC regulation and/or endocytosis (By similarity). CC -!- CATALYTIC ACTIVITY: A phosphatidylcholine + H(2)O = choline + a CC phosphatidate. CC -!- ENZYME REGULATION: Stimulated by phosphatidylinositol 4,5- CC bisphosphate and activated by the ADP-ribosylation factor-1 (ARF- CC 1) (By similarity). CC -!- SUBUNIT: Interacts with EGFR and PIP5K1A (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein (By CC similarity). CC -!- SIMILARITY: Belongs to the phospholipase D family. CC -!- SIMILARITY: Contains 1 PH domain. CC -!- SIMILARITY: Contains 2 PLD phosphodiesterase domains. CC -!- SIMILARITY: Contains 1 PX (phox homology) domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; BT026202; ABG67041.1; -; mRNA. DR EMBL; BC123547; AAI23548.1; -; mRNA. DR IPI; IPI00704116; -. DR RefSeq; NP_001069295.1; -. DR UniGene; Bt.1009; -. DR GeneID; 522159; -. DR KEGG; bta:522159; -. DR HOVERGEN; Q0V8L6; -. DR BRENDA; 3.1.4.4; 251. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0070290; F:NAPE-specific phospholipase D activity; IEA:EC. DR GO; GO:0035091; F:phosphoinositide binding; IEA:InterPro. DR GO; GO:0004630; F:phospholipase D activity; IEA:EC. DR GO; GO:0005515; F:protein binding; IEA:InterPro. DR GO; GO:0007154; P:cell communication; IEA:InterPro. DR GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. DR InterPro; IPR015679; Phospholipase_D. DR InterPro; IPR001849; Pleckstrin_homology. DR InterPro; IPR001736; PLipase_D/transphosphatidylase. DR InterPro; IPR016555; PLipase_D_euk. DR InterPro; IPR001683; PX. DR Gene3D; G3DSA:3.30.1520.10; PX; 1. DR PANTHER; PTHR18896; Phospholipase_D; 1. DR Pfam; PF00614; PLDc; 2. DR Pfam; PF00787; PX; 1. DR PIRSF; PIRSF009376; Phospholipase_D_euk; 1. DR SMART; SM00233; PH; 1. DR SMART; SM00155; PLDc; 2. DR SMART; SM00312; PX; 1. DR PROSITE; PS50003; PH_DOMAIN; FALSE_NEG. DR PROSITE; PS50035; PLD; 2. DR PROSITE; PS50195; PX; 1. PE 2: Evidence at transcript level; KW Hydrolase; Lipid degradation; Membrane; Repeat. FT CHAIN 1 933 Phospholipase D2. FT /FTId=PRO_0000253038. FT DOMAIN 65 195 PX. FT DOMAIN 203 311 PH. FT DOMAIN 437 464 PLD phosphodiesterase 1. FT DOMAIN 751 778 PLD phosphodiesterase 2. FT REGION 441 788 Catalytic. SQ SEQUENCE 933 AA; 105766 MW; 8B5C417338397455 CRC64; MAATPQSLFP SGDDLDSSQL QMEPDEVDTL KEGEDPADRM HPFLAIYHLQ PLKLHPLVFA PGVPVIAQVV GTERYTSGSK VGTCTLYSVR LTHGDFTWTT KKKFRHFQEL HRDLLRHKVF MSLLPLARFA VASSPAPEGD SREIPSLPRA GPEGSSRRTA SKQKYLENYL NRLLTMSFYR NYHAMTEFLE VSQLSFIPDL GCKGLEGVIR KRSGGHRVPG LTCCGRDQVC YRWSKRWLVV KDSFLLYMCL ETGAISFVQL FDPGFKVQVG KRSTEARYGV RVDTSHRSLI LKCSSYRQAR WWAQEITELA QGPGRDFIQL HRHDSYAPPR PGTLARWFVN GAGYFAAVAD AILRAQEEIF ITDWWLSPEI YLKRPAHSDD WRLDIMLKKK AEEGVHVSVL LFKEVELALA INSGYSKKAL MLLHPNIKVM RHPDQVTLWA HHEKLLVVDQ VVAFLGGLDL AYGRWDDLHY RLTDLGDSSE SAAPQPPTSC SDLPATPDLT HNQLFWLGKD YSNLITKDWV QLDRPFDDFI DRETMPRMPW RDIGVVVHGS PARDLARHFI QRWNFTKTTK TKYKIPIYPY LLPKSTSTAN QLPFTLSGGQ CATVQVLRSV DRWSAGTLEN SILNAYLHTI RESQHFLYIE NQFFISCSDG RTVLNKVGDE IVDRILKAHK QGQCFRVYVL LPLLPGFEGD ISTGGGNSIQ AILHFTYRTL CRGEYSILHR LKAAMGTEWR NYISVCGLRT HGELGGHPVS ELIYIHSKML IADDRTVIIG SANINDRSLL GKRDSELAVL IEDTEMEPSL MNGVEYQAGR FALSLRKHCF SVILGAAARP HLDLRDPVCD AFFQLWQDTA ESNANIYEQI FRCLPSNATR SLRALREYVV VEPLATVSPP LARSELNQVQ GHLVHFPLKF LEDEYLLPSL GSKEGVMPLE VWT //